Resolution of statin-induced myalgias by correcting vitamin D deficiency

Southern Medical Journal

Volumn 104, Issue 5, 2011, Pages 380-

  Fang, Shaokuan ^a   Wu, Jiang ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; STATIN; UBIDECARENONE; VITAMIN D;

DRUG EFFICACY; DRUG INDUCED DISEASE; GEOGRAPHIC DISTRIBUTION; HUMAN; LETTER; MUSCULOSKELETAL PAIN; MYALGIA; MYOPATHY; SEASONAL VARIATION; SKELETAL MUSCLE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MUSCULAR DISEASES; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 79955592820     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318213d123     Document Type: Letter

References (4)

1. Bell DS. Resolution of statin-induced myalgias by correcting vitamin D deficiency. South Med J 2010;103:690-692.
2. Harper CR, Jacobson TA. Evidence-based management of statin myopathy. Curr Atheroscler Rep 2010;12:322-330.
3. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 2004;229:1136-1142. (Pubitemid 39602256)
4. Fabbriciani G, Pirro M, Leli C, et al. Diffuse musculoskeletal pain and proximal myopathy: Do not forget hypovitaminosis D. J Clin Rheumatol 2010;16:34-37.